Huons Recalls Lidocaine Injection and Bupivacaine in Dextrose Injection

On May 27, 2025, Huons Co. Ltd. initiated voluntary recalls of lidocaine HCl injection and bupivacaine HCl in dextrose injection for all lots. The recall was prompted by quality issues identified during a recent FDA manufacturing facility inspection, with a potential health hazard, including a small number of reports of drug ineffectiveness. Lidocaine HCl injection is approved to produce local or regional anesthesia, and bupivacaine HCl in dextrose injection is FDA‑approved for spinal anesthesia. This recall represents an expansion impacting additional re-packagers not identified in prior recalls reported in April 2026. To read about the latest recall, please see here.